{"nct_id":"NCT02798991","title":"A Phase I, Randomized, Placebo-controlled, Double Blind, Repeat Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Gastrointestinal Transit Time and Pharmacodynamic Biomarkers of GSK3179106 in Normal Subjects","status":"COMPLETED","status_verified_date":"2017-01","start_date":"2016-06","start_date_type":null,"primary_completion_date":"2016-11","primary_completion_date_type":"ACTUAL","completion_date":"2016-11","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}